ALFA Filings
Every announcement, straight from the exchange
Every Genomic Valley Biotech other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements with these filters
Genomic Valley Biotech Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026. This mandatory disclosure provides details on the company's shareholding structure.
Genomic Valley Biotech Limited received approval from the Registrar of Companies to extend the AGM deadline for FY26 to 31st December 2026. This is a regulatory compliance update.
Genomic Valley Biotech Ltd's promoter, Yogesh Agrawal, declared that the promoter group made no direct or indirect encumbrances on their shareholding during FY 2025-26. This disclosure complies with SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.